We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Help improve GOV.UK Sign up to take part in user research (opens in a new tab)
G7 Leaders' call on the fight against cancer.
First published during the 2024 to 2026 Starmer Labour government
MHRA and FDA liaison programme announced to improve regulatory collaboration and support long-standing international partnership.
Dr Nicola Rose, Executive Director of Science and Research at the Medicines and Healthcare products Regulatory Agency (MHRA), has been appointed an OBE in the 2026 King’s Birthday Honours, for services to science and public …
As with any medicine, the MHRA will keep the safety and effectiveness of the adrenaline nasal spray under close review.
Two-dose MenB vaccine to be offered to young people ahead of the autumn as part of a one-off vaccination programme in England.
The Health and Social Care Secretary gave the keynote speech at the NHS ConfedExpo 2026 conference in Manchester.
Having met the MHRA’s rigorous standards of safety, quality and effectiveness, the semaglutide tablet has been approved in the UK for weight loss and weight management.
The MHRA is publishing the results of an extensive public consultation which will inform the recommendations of the AI Commission and future regulations.
Measles activity increased earlier this year, mainly due to outbreaks in London and the West Midlands.
The government will offer flu vaccination to those experiencing homelessness, beginning in autumn.
UKHSA publishes its first Health Security Risk Assessment (HSRA), which characterises the most significant health security risks facing the UK over the next 5 years.
Government invests in artificial intelligence (AI) technologies to modernise the NHS and reduce waiting times.
There was a national service at St. Paul’s Cathedral for the infected blood community on Tuesday 19th May 2026.
This circular draws attention to temporary controls which are being placed on 7 orphines, which will come into force on 11 June 2026.
This circular describes changes in the legislation on drug precursor chemicals (DPCs).
The London sandbox is a secure environment designed to safely test AI-enabled devices in a real-world environment so patients can benefit more quickly.
New AI sandbox will help make medicines safer, speed up development, and reduce reliance on animal testing.
As with all medicines, the MHRA will keep the safety and effectiveness of Nipolcalimab under close review.
The annual flu letter describes the national flu immunisation programme and outlines which groups are eligible for flu vaccination.
Government consults on new rights for unpaid carers and parents of seriously ill children, including whether paid leave could improve job opportunities.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).